MRD-negative status signals better outcomes in CAR T–treated ALLJune 5, 2018Immuno-oncologyLeukemia, Myelodysplasia, TransplantationImmunotherapyLymphoma & Plasma Cell Disorders
Older CLL and NHL patients are more vulnerable to toxicitiesMay 23, 2018Lymphoma & Plasma Cell Disorders
New regimens for youth with T-cell malignancies yield best outcomes yetMay 19, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatrics
5-year data show deepening response with ibrutinib in CLLMay 11, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Novel targeted cancer drugs cause fewer arrhythmiasMay 8, 2018Patient & Survivor CareBreast CancerLymphoma & Plasma Cell Disorders
Early results favor combo IL-15/anti-CD20 in indolent NHLMay 3, 2018Lymphoma & Plasma Cell DisordersFollicular Lymphoma
